Aridis Pharmaceuticals, Inc. (ARDS)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1 Million | 1.02 Million | 2.75 Million | 860 Thousand |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | 1 Million | 1.02 Million | 2.75 Million | 860 Thousand |
| Operating Expenses | 29.99 Million | 43.71 Million | 23.4 Million | 30.1 Million | 26.87 Million | 20.59 Million |
| Selling, General and Administrative Expenses | 7.16 Million | 7.31 Million | 6.44 Million | 6.02 Million | 3.87 Million | 3.16 Million |
| Research and Development Expenses | 25.92 Million | 37.93 Million | 16.95 Million | 24.08 Million | 23 Million | 17.43 Million |
| Other Expenses | -3.09 Million | -1.53 Million | - | - | - | - |
| Cost and Expenses | 29.99 Million | 43.71 Million | 23.4 Million | 30.1 Million | 26.87 Million | 20.59 Million |
| Operating Income | -29.99 Million | -43.71 Million | -22.4 Million | -29.08 Million | -24.11 Million | -19.73 Million |
| Interest Expense | 378 Thousand | -245 Thousand | - | - | 420 Thousand | - |
| Income Tax Expense | 378 Thousand | -912 Thousand | -414 Thousand | -695 Thousand | 2.43 Million | 4.91 Million |
| Earnings before Tax | -30.37 Million | -43.19 Million | -22.33 Million | -29.68 Million | -22.1 Million | -24.65 Million |
| Net Income | -30.74 Million | -42.28 Million | -21.91 Million | -28.98 Million | -22.1 Million | -24.65 Million |
| Earnings Per Share Basic | -1.64 | -3.44 | -2.39 | -3.43 | -7.02 | -3.12 |
| Earnings Per Share Diluted | -1.64 | -3.44 | -2.39 | -3.43 | -7.02 | -3.12 |
| Weighted Average Shares Outstanding | 18.77 Million | 12.29 Million | 9.16 Million | 8.45 Million | 3.14 Million | 7.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.77 Million | 12.29 Million | 9.16 Million | 8.45 Million | 3.14 Million | 7.89 Million |
| Gross Margin | - | - | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | - | -22.40 | -28.46 | -9.34 | -16.89 |
| Profit Margin | - | - | -21.92 | -28.36 | -8.02 | -28.67 |
| EBITDA | -29.5 Million | -44.43 Million | -22.06 Million | -28.74 Million | -23.83 Million | -19.67 Million |
| Earnings Before Tax Margin | - | - | -22.40 | -28.46 | -8.75 | -22.95 |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 417 Thousand | 19.64 Million | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 417 Thousand | 19.64 Million | - | - | - | - |
| Operating Expenses | 869 Thousand | 5.97 Million | 6.26 Million | 29.99 Million | 7.42 Million | 7.41 Million |
| Selling, General and Administrative Expenses | 1.11 Million | 1.31 Million | 1.81 Million | - | 1.62 Million | 1.69 Million |
| Research and Development Expenses | 175 Thousand | 4.66 Million | 5.53 Million | - | 7 Million | 6.11 Million |
| Other Expenses | 785 Thousand | -1.52 Million | -1.08 Million | -3.09 Million | -1.21 Million | -399 Thousand |
| Cost and Expenses | 869 Thousand | 5.97 Million | 6.26 Million | 29.99 Million | 7.42 Million | 7.41 Million |
| Operating Income | -869 Thousand | 13.66 Million | -6.26 Million | -29.99 Million | -7.42 Million | -7.41 Million |
| Interest Expense | 1000.00 | 3000.00 | 27 Thousand | 378 Thousand | -1.03 Million | -27 Thousand |
| Income Tax Expense | -60 Thousand | -3000.00 | 526 Thousand | 378 Thousand | -1.03 Million | 827 Thousand |
| Earnings before Tax | -83 Thousand | 12.14 Million | -6.81 Million | -30.37 Million | -6.38 Million | -8.23 Million |
| Net Income | -83 Thousand | 12.14 Million | -7.34 Million | -30.74 Million | -5.35 Million | -9.06 Million |
| Earnings Per Share Basic | -0.00 | 0.34 | -0.24 | - | -0.24 | -0.51 |
| Earnings Per Share Diluted | -0.00 | 0.33 | -0.24 | - | -0.24 | -0.51 |
| Weighted Average Shares Outstanding | 37.42 Million | 36.07 Million | 30.41 Million | 18.77 Million | 22 Million | 17.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.42 Million | 36.57 Million | 30.41 Million | 18.77 Million | 22 Million | 17.7 Million |
| Gross Margin | 1.00 | 1.00 | - | - | - | - |
| EBIT Margin | -2.08 | 0.70 | - | - | - | - |
| Profit Margin | -0.20 | 0.62 | - | - | - | - |
| EBITDA | -869 Thousand | 13.73 Million | -6.17 Million | - | -7.32 Million | -7.28 Million |
| Earnings Before Tax Margin | -2.08 | 0.70 | - | - | - | - |
SCHW-PJ
CRES
XYL
SEER
RAPP
TAR